Stage-specific Case Management for Early Psychosis

NCT00919620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2020-11-13

No results posted yet for this study

Summary

One of the commonly adopted strategies in improving outcome in psychotic disorders is by focused, specific and intensive intervention in the initial few years of the disorder. However the effects of intervention and the optimal duration of intervention have seldom been examined in randomized studies. This study uses a randomized controlled study design to investigate the effectiveness of stage-specific case-management in improving outcome of first episode psychotic disorders. It also addresses whether two years of case-management is less effective than four years of case-management over a four year period. A total of 360 subjects, who aged 25 above, and diagnosed with first episode psychotic disorders, will be and randomized into 3 groups: (1) standard care alone without case management, (2) two-year case management, (3) four-year case management. All groups will receive usual standard care treatment. This four-year follow-up study will assess symptoms, functioning, quality of life as well as health economics data.

Conditions

  • Psychotic Disorders

Interventions

BEHAVIORAL

stage-specific case-management

Stage-specific case-management for psychosis by designated key-workers according to specified protocol

Sponsors & Collaborators

  • Queen Mary Hospital, Hong Kong

    collaborator OTHER
  • Kwai Chung Hospital

    collaborator OTHER
  • Kowloon Hospital, Hong Kong

    collaborator OTHER
  • Castle Peak Hospital

    collaborator OTHER_GOV
  • Shatin Hospital

    collaborator OTHER
  • Tai Po Hospital

    collaborator OTHER_GOV
  • North District Hospital, Hong Kong

    collaborator UNKNOWN
  • United Christian Hospital

    collaborator OTHER
  • Queen Elizabeth Hospital, Hong Kong

    collaborator OTHER
  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Eric YH Chen, MD · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
26 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00919620 on ClinicalTrials.gov